Skip to main content
Earnings Labs
Liminatus Pharma, Inc. Class A Common Stock logo

Liminatus Pharma, Inc. Class A Common Stock (LIMN) Earnings

NASDAQ·Healthcare·Biotechnology

$0.13

-7.57%

Mkt Cap $6.34M

EPS — Estimate vs Actual

Mkt Cap

$6.34M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$2.91